Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050232
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2002-12-02
Brief Title:
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Organization Data
Organization:
Avanir Pharmaceuticals
Class:
INDUSTRY
Study ID:
02-AVR-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avanir Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None